Frank Vinluan - Profile and Journalist Details
Find journalists that align with your industry, location and vision. Unlock Frank Vinluan's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.
Get connected with journalists today
Frank Vinluan
Verified
Senior Biopharma Reporter, MedCity News
North Carolina
Beats
Gambling expansion particularly emerging and launching online casinos and sports betting markets. Focusing on North Carolina for 2024 sports betting launch.
Content
By Frank Vinluan Verified| MedCity News Verified Drugs have been the standard migraine treatment for decades. The severe headaches, nausea, and other problems associated with this common disorder now have a digital treatment option, a mobile app developed by prescription digital medicines developer Click Therapeutics. The FDA marketing authorization announced Tuesday permits use of the Click digital therapeutic for the prevention of episodic migraine in patients age 18 and older.
By Frank Vinluan Verified, Tomasz Rezik| MedCity News Verified Pfizer is playing catch-up in the crowded field of obesity medicines, but it hoped to compete with a daily pill alternative to currently available injectable GLP-1 products. Instead, Pfizer is stopping development of its drug, danuglipron, after a liver complication emerged in a clinical trial. The pharmaceutical giant was evaluating danuglipron in two Phase 1 dose-optimization studies. The company said Monday a patient in one of those studies experienced a potential drug-induced liver injury.
By Frank Vinluan Verified| MedCity News Verified Drugs have been the standard migraine treatment for decades. The severe headaches, nausea, and other problems associated with this common disorder now have a digital treatment option, a mobile app developed by prescription digital medicines developer Click Therapeutics. The FDA marketing authorization announced Tuesday permits use of the Click digital therapeutic for the prevention of episodic migraine in patients age 18 and older.
Company Info
MedCity News
MedCity News is a prominent online news source dedicated to the business of innovation in healthcare. Founded in 2009 and based in New York City, the company provides valuable insights into healthcare technology and life sciences. It serves busy professionals and senior executives in the healthcare sector. The company offers comprehensive news coverage on various topics, including healthcare technology and current industry events. MedCity News also provides a daily newsletter to keep subscribers informed about the latest trends and developments. In-depth analysis and insights into healthcare innovations are key features of their content, helping readers understand important industry shifts. With an annual revenue of $2 million and a team of around 16 employees, MedCity News plays a significant role in the media and information services sector, specifically within healthcare and life sciences. It competes with other notable healthcare news outlets, delivering high-quality content to a diverse audience of healthcare professionals, investors, and industry leaders.
New York, New York, United States
+1 216-453-2662
Founded: 2009